Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon

Renal denervation: Brightest hope since angioplasty?

Medical advances are announced at breakneck speed, many heralded as the greatest breakthrough since antibiotics or anesthesia. Although most don’t live up to the hype, some find a valuable if limited role in the clinician’s arsenal. Renal sympathetic denervation may prove to be one of those.

FDA green-lights Xience Xpedition stent

The FDA has approved Abbott's Xience Xpedition everolimus-eluting coronary stent system, which the company is launching immediately in the U.S. The Xience Xpedition features a new stent delivery system and a larger size matrix.

ICD survival rates similar in clinical trials, practice

Researchers comparing patients who received implantable cardioverter-defibrillators (ICDs) in clinical trials and patients in an ICD registry found no significant differences in survival rates between the two groups, but ICD patients had significantly improved survival rates over those patients in clinical trials who received medical treatment only. The Journal of the American Medical Association published these findings Jan. 2.

Hearing set in Mo. overstenting case

A Missouri cardiologist whose license was suspended on Nov. 9, 2012, after he was accused of improperly stenting six patients has been given an administrative hearing date of Feb. 4.

Covidien buys PAD device maker

Covidien has signed a definitive agreement to acquire CV Ingenuity, a company that provides technologies to relieve vascular obstructions, inhibit restenosis and allow natural vessel healing in patients with peripheral arterial disease (PAD).

Eliquis wins regulatory approvals in U.S., Japan

The end of the year has proved to be joyous for Bristol-Myers Squibb and Pfizer, whose anticlotting drug apixaban (Eliquis) received back-to-back approvals by the FDA in the U.S. and the Ministry of Health, Labor and Welfare in Japan.

FDA approves Juxtapid for rare cholesterol disease

The FDA has approved lomitapide (Juxtapid, Aegerion Pharmaceuticals) to reduce cholesterol in patients with homozygous familial hypercholesterolemia, but the drug's labeling included a boxed warning citing the risk of liver toxicity.

FDA clears Avinger's CTO catheter

Avinger, a medical device manufacturer of imaging catheters for crossing chronic total occlusions (CTOs) in patients with peripheral artery disease, has received FDA clearance to market Ocelot | PIXL in the U.S.

Displaying 8433 - 8440 of 10761

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.